1. Home
  2. NUVL vs FRT Comparison

NUVL vs FRT Comparison

Compare NUVL & FRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NUVL
  • FRT
  • Stock Information
  • Founded
  • NUVL 2017
  • FRT 1962
  • Country
  • NUVL United States
  • FRT United States
  • Employees
  • NUVL N/A
  • FRT N/A
  • Industry
  • NUVL Biotechnology: Pharmaceutical Preparations
  • FRT Real Estate Investment Trusts
  • Sector
  • NUVL Health Care
  • FRT Real Estate
  • Exchange
  • NUVL Nasdaq
  • FRT Nasdaq
  • Market Cap
  • NUVL 7.1B
  • FRT 8.4B
  • IPO Year
  • NUVL 2021
  • FRT N/A
  • Fundamental
  • Price
  • NUVL $109.19
  • FRT $96.94
  • Analyst Decision
  • NUVL Strong Buy
  • FRT Hold
  • Analyst Count
  • NUVL 13
  • FRT 13
  • Target Price
  • NUVL $133.85
  • FRT $109.23
  • AVG Volume (30 Days)
  • NUVL 734.4K
  • FRT 743.5K
  • Earning Date
  • NUVL 10-30-2025
  • FRT 10-31-2025
  • Dividend Yield
  • NUVL N/A
  • FRT 4.70%
  • EPS Growth
  • NUVL N/A
  • FRT 14.84
  • EPS
  • NUVL N/A
  • FRT 3.95
  • Revenue
  • NUVL N/A
  • FRT $1,257,396,000.00
  • Revenue This Year
  • NUVL N/A
  • FRT $5.42
  • Revenue Next Year
  • NUVL N/A
  • FRT $5.19
  • P/E Ratio
  • NUVL N/A
  • FRT $24.40
  • Revenue Growth
  • NUVL N/A
  • FRT 6.11
  • 52 Week Low
  • NUVL $55.54
  • FRT $80.65
  • 52 Week High
  • NUVL $112.88
  • FRT $118.09
  • Technical
  • Relative Strength Index (RSI)
  • NUVL 66.08
  • FRT 47.66
  • Support Level
  • NUVL $93.05
  • FRT $95.14
  • Resistance Level
  • NUVL $112.53
  • FRT $99.25
  • Average True Range (ATR)
  • NUVL 5.84
  • FRT 1.97
  • MACD
  • NUVL 1.06
  • FRT -0.01
  • Stochastic Oscillator
  • NUVL 84.34
  • FRT 74.40

About NUVL Nuvalent Inc.

Nuvalent Inc is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of the Company's operations are in the United States. The company is engaged in developing small molecules that are designed to overcome the limitations of existing therapies for clinically validated kinase targets. The product candidates of the company include NVL-520, which is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC), NVL-655, which is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to address the combined medical need of treating tumors driven by HER2ex20.

About FRT Federal Realty Investment Trust

Federal Realty Investment Trust is a shopping center-focused retail real estate investment trust that owns high-quality properties in eight of the largest metropolitan markets. Its portfolio includes an interest in 102 properties, which includes 27.4 million square feet of retail space and 3,000 multifamily units. Federal's retail portfolio includes grocery-anchored centers, superregional centers, power centers, and mixed-use urban centers. Federal Realty has focused on owning assets in highly desirable areas with significant growth, and as a result, the average population density and average median household income are higher for its portfolio than for any other retail REIT.

Share on Social Networks: